Medical Network March 16 News Russian Satellite News Agency March 13th, according to the Russian Penza State Government website news, a Sino-Russian joint venture of trauma and orthopedic equipment factory will be put into operation in June 2018. The source pointed out that the Chinese side Investor is Natto Medical Group.
As early as August 2016, there was news from Russia that Natto Medical Group and Russia's Titanmed and MedEnj would set up joint production plants for orthopedic products in Penza. According to sources, the joint venture company was based in Penza, Lameyer. 'Technology Park, at the time the registration process was opened.
However, another Russian news website reported that on December 8, 2016, the Penza State Government and Moscow Titanmed signed a memorandum of cooperation with Shanghai Bojin Medical Devices Co., Ltd. to establish a joint venture in Penza Prefecture. The governor of Penza Prefecture will also personally supervise and ensure the implementation of the project to establish a joint production plant for Russian orthopedic products. This news can also be found on the official website of Shanghai Bojin.
The two messages contradicted each other. At present, it can be confirmed that Chinese and Russian companies have jointly built an orthopedic device manufacturing plant in Russia. However, the two investors are still waiting for further confirmation.
Among the two suspected Chinese companies, Natto Medical Group was founded in 1996, started with orthopedics business, and continued to expand its product lines and business areas. At present, the group already has a number of medical device manufacturing companies, such as Tianjin Orthopaedic, a well-known orthopedic consumables company. Tianli Company, dental implant manufacturer Beijing Leiden Company, Finnish biodegradable material company Fin Inion Company, etc., is also a German domestic WALDEMAR LINK product domestic proxy.
Shanghai Bojin medical instruments Founded in 199, the company mainly manufactures medical electric saws, hand-held portable X-ray fluoroscopes, fracture therapy instruments, and orthopaedic tools.
Russia participating in investment enterprise - Moscow Titanmed company was founded in 2010, engaged in the supply of surgical implants.
Another company, Pessa MedEnj, which was involved in the establishment of the Russian company, was established in 1994 and mainly engaged in labor heart Valve production, which holds 65% of the medical product market in Russia.
$1.5 billion, Chinese companies plan to build medical equipment base in Russia
In addition, in 2017, the Ulyanovsk State Government of Russia had news that Chinese companies plan to establish a medical equipment production base in the Special Economic Zone of Ulyanovsk Region.
The project will have a total investment of approximately US$1.5 billion by 2026. It plans to produce X-ray machine digital detectors, high-tech telemedicine equipment, and construction of logistics centers, scientific research institutions, etc.
According to sources, the implementer of this $1.5 billion investment project is the 'NTM' group.
At present, it is unclear whether this 'NTM' group is an abbreviation of NATON MEDICAL GROUP or is it another company.
Dabo Medical also wants to build a joint venture plant in Russia
Coincidentally.
Dabo Medical Technology Co., Ltd., another orthopedic consumable manufacturer that was listed on the Shenzhen Stock Exchange last year, issued an announcement in December last year to establish a subsidiary in Russia and Chile.
Dabo Medical plans to establish Dabo Medical (Russia) Co., Ltd. in the Russian state of Colomevo, where Dabo Medical holds 75% of the shares, and another two Russian citizens each hold 12.5% of the shares. The company will mainly be engaged in orthopaedics and nerves. Surgical and other medical device product development, production and sales.
Dabo Medical intends to establish Dabo Medical (Chile) Co., Ltd. in Santiago, Chile. The company is mainly engaged in the sales of medical equipment products such as orthopedics and neurosurgery. Dabo Medical holds 100% of its equity.
Dabo Russia plans to invest a total of 1.606 million U.S. dollars in 2017-2022, not only to sell orthopaedic medical devices in Russia, but also to set up factories.
Dabo Medical stated that the establishment of a company in Russia and Chile is an important measure for the company's internationalization strategy. It is intended to open up two potential medical device markets in Central and Eastern Europe and South America.
Sino-Russian Negotiating to Build Medical Consumables Enterprises in Russia
In December 2016, the Ministry of Industry and Trade of the Russian Federation also publicly stated that Russia and China are studying the establishment of medical device manufacturing plants in Russia.
In October of that year, the First Deputy Minister of Industry and Trade of the Russian Federation discussed the implementation of investment projects in three industrial enterprises during the meeting with the chairman of the Zhongji Engineering Company. The three companies were specialized in producing reusable technology. Medical devices, including syringes.
In fact, it is a one-time consumables company.
A new era of Chinese medical machinery companies going to sea
China's medical device companies are marching overseas. They are ushering in a new era of diversification and flowering.
Not only export products, such as 'big dressing giants', Zhende, Ogilvy & Mather, and so on, but also Mindray, which sells medical equipment, and Minimally Invasive, which sells high-value consumables, have already made foreign markets equal to the domestic market. , Even accounting for a heavier point.
There are money-saving mergers and acquisitions, buying companies, buying technology, buying products, and buying brands. This route is also the most common one. It targets many developed regions such as Europe and the United States and emerging hot spots like Israel.
In this area, in recent years, more and more companies have participated in the new participation, and the amount of single mergers and acquisitions has also grown.
Typical M&A cases, such as Weigao's $5.6 billion purchase of Aiwa, Chutian Technology's RMB 1.1 billion acquisition of the German ROMACO Group, Wandong and Yunfeng Fund, etc., together with 1.9 billion to buy yum, minimally inventing 1.2 billion to buy Sorin, and 5.3 billion for Bluefan. Buy Bai Sheng International, three Sino Biological bought 1.4 billion American blood glucose meter manufacturers, and they are interested in bidding for Johnson & Johnson business.
There are also direct investment in setting up subsidiaries or joint venture companies overseas. Many of them even invest in factories and build R&D and manufacturing bases or centers abroad.
Typically, for instance, Yuyue Medical set up a wholly-owned subsidiary in Tuttlingen, Germany, to make a leap from manufacturing in Germany. Also, for example, the aforementioned Naton (Bojin), Dabo, etc. invest in Russia/JV Build a factory.
Judging from the industry dynamics of the industry, Russia is becoming a sea choice for some powerful Chinese medical device companies. This shows that after more than ten years of rapid development, the Chinese medical device industry has been synchronized with the world in some areas of technology. With the globalization of resources allocation, the output of external capital also outputs the strength of technology.
Chinese medical device companies are trying to take a new look to the world. This is a bold exploration, risky and challenging, such as awareness of Chinese brands, cultural differences, legal disputes, etc., but there is also a vast market space and The temptation of the foreground.
And not only Russia, but more of its own medical industry is weak, depending heavily on imported countries, or it may become a choice for Chinese medical device companies.
As a national strategy, the 'One Belt and One Road' initiative provides an opportunity, and industry players are ready to go.
For example, medical device companies including Kangda Medical, Lepu Medical, Meikang Biotech, Kellytek, and Vizcau Guanghua convened a medical industry “Belt and Road” work conference at the end of last year. The 'Belt and Road' countries have discussed.
In the wind and waves, China's medical device companies will once again go to sea, and who will be next?! Where will they go?
